Related Experiment Video
Updated: Jun 19, 2026
12:22
The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Genetic profiles in renal tumors
Antonio Lopez-Beltran1, Rodolfo Montironi, Lars Egevad
1Department of Pathology and Surgery, Cordoba University, Cordoba, Spain. em1lobea@uco.es
Summary
Molecular genetics advances renal cell carcinoma classification and understanding of tumor development. This knowledge aids in accurate diagnosis, prognosis, and targeted therapies for kidney cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Renal cell carcinoma (RCC) is a diverse kidney cancer with unpredictable clinical behavior.
- Molecular genetics has significantly improved the classification and understanding of RCC development.
- Identifying specific genetic alterations is key to understanding RCC pathogenesis.
Purpose of the Study:
- To review the molecular genetic profiles of various renal cell tumors.
- To discuss the role of these profiles in carcinogenesis and clinical diagnosis.
- To highlight the clinical utility of understanding RCC molecular genetics.
Main Methods:
- Review of current literature on molecular genetics of renal cell tumors.
- Analysis of published data on genetic alterations in different RCC subtypes.
- Synthesis of information linking molecular profiles to clinical outcomes.
Main Results:
- Molecular genetic data has refined the classification of renal neoplasms.
- Specific genetic alterations are associated with distinct RCC subtypes and behaviors.
- Understanding these profiles offers insights into tumor development and progression.
Conclusions:
- Molecular genetics provides crucial insights into renal cell carcinoma carcinogenesis.
- Accurate diagnosis and prognosis of RCC are enhanced by understanding molecular profiles.
- Targeted therapeutic strategies for kidney cancer can be informed by molecular data.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...